PT  - JOURNAL ARTICLE
AU  - Hauser, Stephen L.
AU  - Fosburg, Martin
AU  - Kevy, Sherwin V.
AU  - Weiner, Howard L.
TI  - Lymphocytapheresis in chronic progressive multiple sclerosis
AID  - 10.1212/WNL.34.7.922
DP  - 1984 Jul 01
TA  - Neurology
PG  - 922--922
VI  - 34
IP  - 7
4099  - http://n.neurology.org/content/34/7/922.short
4100  - http://n.neurology.org/content/34/7/922.full
SO  - Neurology1984 Jul 01; 34
AB  - We studied the effects of lymphocytapheresis in five patients with chronic progressive MS. Ten lymphocytapheresis treatments were given in 2 weeks, followed by 1 treatment every 2 weeks for 2 to 6 months. Four of five patients had a fall in the circulating lymphocyte count during the initial treatment, and in three patients a modest lymphopenia was sustained with maintenance therapy. In patients with abnormal T4:T8 ratios, no improvement in the T4:TS ratio occurred. There was no apparent clinical effect in this pilot study.